Literature DB >> 17075134

Backbone dynamics of SDF-1alpha determined by NMR: interpretation in the presence of monomer-dimer equilibrium.

Olga K Baryshnikova1, Brian D Sykes.   

Abstract

SDF-1alpha is a member of the chemokine family implicated in various reactions in the immune system. The interaction of SDF-1alpha with its receptor, CXCR4, is responsible for metastasis of a variety of cancers. SDF-1alpha is also known to play a role in HIV-1 pathogenesis. The structures of SDF-1alpha determined by NMR spectroscopy have been shown to be monomeric while X-ray structures are dimeric. Biochemical data and in vivo studies suggest that dimerization is likely to be important for the function of chemokines. We report here the dynamics of SDF-1alpha determined through measurement of main chain (15)N NMR relaxation data. The data were obtained at several concentrations of SDF-1alpha and used to determine a dimerization constant of approximately 5 mM for a monomer-dimer equilibrium. The dimerization constant was subsequently used to extrapolate values for the relaxation data corresponding to monomeric SDF-1alpha. The experimental relaxation data and the extrapolated data for monomeric SDF-1alpha were analyzed using the model free approach. The model free analysis indicated that SDF-1alpha is rigid on the nano- to picosecond timescale with flexible termini. Several residues involved in the dimer interface display slow micro- to millisecond timescale motions attributable to chemical exchange such as monomer-dimer equilibrium. NMR relaxation measurements are shown to be applicable for studying oligomerization processes such as the dimerization of SDF-1alpha.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17075134      PMCID: PMC2242403          DOI: 10.1110/ps.062255806

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  46 in total

1.  The stepwise binding of small molecules to proteins. Nuclear magnetic resonance and temperature jump studies of the binding of 4-(N-acetylaminoglucosyl)-N-acetylglucosamine to lysozyme.

Authors:  J H Baldo; S E Halford; S L Patt; B D Sykes
Journal:  Biochemistry       Date:  1975-05-06       Impact factor: 3.162

Review 2.  Chemokines in autoimmunity: from pathology to therapeutics.

Authors:  Steven L Kunkel; Nuria Godessart
Journal:  Autoimmun Rev       Date:  2002-12       Impact factor: 9.754

3.  Solution structure and dynamics of the CX3C chemokine domain of fractalkine and its interaction with an N-terminal fragment of CX3CR1.

Authors:  L S Mizoue; J F Bazan; E C Johnson; T M Handel
Journal:  Biochemistry       Date:  1999-02-02       Impact factor: 3.162

4.  The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases.

Authors:  Roderick J Phillips; Marie D Burdick; Marin Lutz; John A Belperio; Michael P Keane; Robert M Strieter
Journal:  Am J Respir Crit Care Med       Date:  2003-03-05       Impact factor: 21.405

5.  Crystal structure of viral macrophage inflammatory protein I encoded by Kaposi's sarcoma-associated herpesvirus at 1.7A.

Authors:  John G Luz; Minmin Yu; Ying Su; Zining Wu; Zhou Zhou; Ren Sun; Ian A Wilson
Journal:  J Mol Biol       Date:  2005-10-07       Impact factor: 5.469

6.  NMR exchange broadening arising from specific low affinity protein self-association: analysis of nitrogen-15 nuclear relaxation for rat CD2 domain 1.

Authors:  M Pfuhl; H A Chen; S M Kristensen; P C Driscoll
Journal:  J Biomol NMR       Date:  1999-08       Impact factor: 2.835

7.  Recruitment of osteoclast precursors by stromal cell derived factor-1 (SDF-1) in giant cell tumor of bone.

Authors:  Ted S Liao; Matthew B Yurgelun; Seong-Sil Chang; Hui-Zhu Zhang; Koko Murakami; Theodore A Blaine; May V Parisien; William Kim; Robert J Winchester; Francis Young-In Lee
Journal:  J Orthop Res       Date:  2005-01       Impact factor: 3.494

8.  The monomer-dimer equilibrium of stromal cell-derived factor-1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin.

Authors:  Christopher T Veldkamp; Francis C Peterson; Adam J Pelzek; Brian F Volkman
Journal:  Protein Sci       Date:  2005-03-01       Impact factor: 6.725

Review 9.  Stromal factors involved in prostate carcinoma metastasis to bone.

Authors:  Carlton R Cooper; Christopher H Chay; James D Gendernalik; Hyung-Lae Lee; Jasmine Bhatia; Russell S Taichman; Laurie K McCauley; Evan T Keller; Kenneth J Pienta
Journal:  Cancer       Date:  2003-02-01       Impact factor: 6.860

10.  The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract.

Authors:  K Tachibana; S Hirota; H Iizasa; H Yoshida; K Kawabata; Y Kataoka; Y Kitamura; K Matsushima; N Yoshida; S Nishikawa; T Kishimoto; T Nagasawa
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

View more
  23 in total

1.  Secreted CXCL12 (SDF-1) forms dimers under physiological conditions.

Authors:  Paramita Ray; Sarah A Lewin; Laura Anne Mihalko; Sasha-Cai Lesher-Perez; Shuichi Takayama; Kathryn E Luker; Gary D Luker
Journal:  Biochem J       Date:  2012-03-01       Impact factor: 3.857

2.  Diflunisal targets the HMGB1/CXCL12 heterocomplex and blocks immune cell recruitment.

Authors:  Federica De Leo; Giacomo Quilici; Mario Tirone; Francesco De Marchis; Valeria Mannella; Chiara Zucchelli; Alessandro Preti; Alessandro Gori; Maura Casalgrandi; Rosanna Mezzapelle; Marco E Bianchi; Giovanna Musco
Journal:  EMBO Rep       Date:  2019-08-14       Impact factor: 8.807

3.  NMR in the Analysis of Functional Chemokine Interactions and Drug Discovery.

Authors:  Joshua J Ziarek; Brian F Volkman
Journal:  Drug Discov Today Technol       Date:  2012

4.  Structure-Based Identification of Novel Ligands Targeting Multiple Sites within a Chemokine-G-Protein-Coupled-Receptor Interface.

Authors:  Emmanuel W Smith; Amanda M Nevins; Zhen Qiao; Yan Liu; Anthony E Getschman; Sai L Vankayala; M Trent Kemp; Francis C Peterson; Rongshi Li; Brian F Volkman; Yu Chen
Journal:  J Med Chem       Date:  2016-04-14       Impact factor: 7.446

Review 5.  New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model.

Authors:  Andrew B Kleist; Anthony E Getschman; Joshua J Ziarek; Amanda M Nevins; Pierre-Arnaud Gauthier; Andy Chevigné; Martyna Szpakowska; Brian F Volkman
Journal:  Biochem Pharmacol       Date:  2016-04-19       Impact factor: 5.858

6.  The chemokine X-factor: Structure-function analysis of the CXC motif at CXCR4 and ACKR3.

Authors:  Michael J Wedemeyer; Sarah A Mahn; Anthony E Getschman; Kyler S Crawford; Francis C Peterson; Adriano Marchese; John D McCorvy; Brian F Volkman
Journal:  J Biol Chem       Date:  2020-08-11       Impact factor: 5.157

7.  Mutational Analysis of Atypical Chemokine Receptor 3 (ACKR3/CXCR7) Interaction with Its Chemokine Ligands CXCL11 and CXCL12.

Authors:  Besma Benredjem; Mélanie Girard; David Rhainds; Geneviève St-Onge; Nikolaus Heveker
Journal:  J Biol Chem       Date:  2016-11-14       Impact factor: 5.157

8.  Solution structure of Ca2+-free rat beta-parvalbumin (oncomodulin).

Authors:  Michael T Henzl; John J Tanner
Journal:  Protein Sci       Date:  2007-09       Impact factor: 6.725

9.  Structural basis of the interaction between chemokine stromal cell-derived factor-1/CXCL12 and its G-protein-coupled receptor CXCR4.

Authors:  Yutaka Kofuku; Chie Yoshiura; Takumi Ueda; Hiroaki Terasawa; Takahiro Hirai; Sae Tominaga; Masako Hirose; Yoshitake Maeda; Hideo Takahashi; Yuya Terashima; Kouji Matsushima; Ichio Shimada
Journal:  J Biol Chem       Date:  2009-10-18       Impact factor: 5.157

10.  Heterologous quaternary structure of CXCL12 and its relationship to the CC chemokine family.

Authors:  James W Murphy; Hua Yuan; Yong Kong; Yong Xiong; Elias J Lolis
Journal:  Proteins       Date:  2010-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.